Page last updated: 2024-08-22

methylprednisolone hemisuccinate and Hodgkin Disease

methylprednisolone hemisuccinate has been researched along with Hodgkin Disease in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's2 (40.00)18.2507
2000's2 (40.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Apjok, E; Magyarosy, E; Marosi, A1
Ahmed, T; Chun, H; Coleman, M; Cook, P; Coombe, N; Feldman, E; Helson, L; Mittelman, A; Puccio, C1
Andersson, B; Cabanillas, F; Fayad, L; Hagemeister, FB; McLaughlin, P; Rodriguez, J; Rodriguez, MA; Romaguera, J; Sarris, A; Swan, F1
Braumann, D; Fiedler, F; Hänel, A; Hänel, M; Hoffknecht, MM; Hossfeld, DK; Illiger, HJ; Kröger, N; Krüger, WH; Metzner, B; Peters, SO; Schubert, JC; Weh, HJ; Zander, AR; Zeller, W1
Flombaum, CD; Schroy, P; Vanamee, P; Watson, R1

Trials

3 trial(s) available for methylprednisolone hemisuccinate and Hodgkin Disease

ArticleYear
Phase I-II trial of high dose Ara-C, carboplatinum, etoposide and steroids in patients with refractory or relapsed lymphomas.
    Leukemia, 1994, Volume: 8, Issue:4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cytarabine; Drug Administration Schedule; Etoposide; Female; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Methylprednisolone Hemisuccinate; Middle Aged

1994
ASHAP: a regimen for cytoreduction of refractory or recurrent Hodgkin's disease.
    Blood, 1999, Jun-01, Volume: 93, Issue:11

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Doxorubicin; Female; Hodgkin Disease; Humans; Infusions, Intravenous; Male; Methylprednisolone Hemisuccinate; Middle Aged; Recurrence; Survival Analysis

1999
ASHAP--an effective salvage therapy for recurrent and refractory malignant lymphomas.
    Annals of hematology, 2000, Volume: 79, Issue:6

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Doxorubicin; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Methylprednisolone Hemisuccinate; Middle Aged; Recurrence; Salvage Therapy; Survival Analysis

2000

Other Studies

2 other study(ies) available for methylprednisolone hemisuccinate and Hodgkin Disease

ArticleYear
[Guillain-Barré syndrome in patients treated for Hodgkin disease].
    Orvosi hetilap, 2003, May-25, Volume: 144, Issue:21

    Topics: Adolescent; Anti-Inflammatory Agents; Antineoplastic Combined Chemotherapy Protocols; Guillain-Barre Syndrome; Hodgkin Disease; Humans; Male; Methylprednisolone Hemisuccinate; Neuroprotective Agents; Paraneoplastic Syndromes, Nervous System; Treatment Outcome

2003
Treatment of acute obstructive renal failure with high-dose methylprednisolone.
    Archives of internal medicine, 1986, Volume: 146, Issue:1

    Topics: Acute Kidney Injury; Aged; Edema; Female; Hodgkin Disease; Humans; Injections, Intravenous; Male; Methylprednisolone; Methylprednisolone Hemisuccinate; Ureteral Obstruction; Uterine Cervical Neoplasms

1986